![BiPER Therapeutics raises €1.25 million in seed funding to develop first-in-class small molecules to treat gastrointestinal cancers](https://ala.associates/wp-content/uploads/2023/02/Photo-Pro_Mehdi_CHELBI-Mehdi_2018-08-06-1080x675.jpg)
![BiPER Therapeutics raises €1.25 million in seed funding to develop first-in-class small molecules to treat gastrointestinal cancers](https://ala.associates/wp-content/uploads/2023/02/Photo-Pro_Mehdi_CHELBI-Mehdi_2018-08-06-1080x675.jpg)
![Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)](https://ala.associates/wp-content/uploads/2023/01/1644604852-huge-1-1080x675.jpg)
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)
![DeuterOncology closes €5.65M Series A financing round](https://ala.associates/wp-content/uploads/2023/01/Timothy-Perera-CEO-DeuterOncology-1080x675.png)
DeuterOncology closes €5.65M Series A financing round
![Enalees appoints Eric Germain as managing director](https://ala.associates/wp-content/uploads/2023/01/Eric-Germain-DG-Enalees-scaled-e1673874349455-1080x675.jpg)
Enalees appoints Eric Germain as managing director
![Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project](https://ala.associates/wp-content/uploads/2023/01/Illustration-Phages.jpg)
Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project
![EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer](https://ala.associates/wp-content/uploads/2023/01/Dr-Barthelemy-everImmune-492x675.jpg)
EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer
![Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent](https://ala.associates/wp-content/uploads/2023/01/IMG_9492-scaled-e1639732296679-1080x675.jpg)
Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent
![Ribonexus appoints Steven Powell as CEO](https://ala.associates/wp-content/uploads/2022/12/Steven-Powell-headshot-1-scaled-e1670929254963-1080x675.jpg)
Ribonexus appoints Steven Powell as CEO
![Quest for health accelerator launches in French Grand Est region with focus on healthcare start-ups](https://ala.associates/wp-content/uploads/2022/11/Guillaume-Vetter-Genoud-1080x675.jpg)
Quest for health accelerator launches in French Grand Est region with focus on healthcare start-ups
![BioWin expands its ‘Growth & Financing’ member service by appointing two industry experts](https://ala.associates/wp-content/uploads/2022/11/Bernard-et-Nadia2-1080x675.jpg)